Literature DB >> 26068346

Fluconazole susceptibility of 3,056 clinical isolates of Candida species from 2005 to 2009 in a tertiary-care hospital.

Y Ying, J Zhang, S B Huang, F D Liu, J H Liu, J Zhang, X F Hu, Z Q Zhang, X Liu, X T Huang1.   

Abstract

In recent years, Candida infections have been increasing significantly. This study was to investigate the distribution and fluconazole susceptibility of such infections. Totally, 3,056 clinical isolates were analysed, C. albicans was the most prevalent species from respiratory and vaginal specimens. However, non-albicans species constituted the majority of isolates from blood, urine, intensive care unit (ICU), organ transplant and burned patients. Similarly, Candida spp. from different specimens and clinical services had different degrees of susceptibility to fluconazole. Isolates from vagina and burned patients had the highest resistance rate, while all of the isolates from ascites and dermatological services were susceptible to fluconazole.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26068346     DOI: 10.4103/0255-0857.158569

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  5 in total

Review 1.  Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.

Authors:  Andrew T Nishimoto; Cheshta Sharma; P David Rogers
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790

2.  Detection of ERG11 point mutations in Iranian fluconazole-resistant Candida albicans isolates.

Authors:  Ali Sardari; Hossein Zarrinfar; Rasoul Mohammadi
Journal:  Curr Med Mycol       Date:  2019-03

Review 3.  Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.

Authors:  Sarah G Whaley; Elizabeth L Berkow; Jeffrey M Rybak; Andrew T Nishimoto; Katherine S Barker; P David Rogers
Journal:  Front Microbiol       Date:  2017-01-12       Impact factor: 5.640

4.  In vitro inhibitory activities of magnolol against Candida spp.

Authors:  Peiru Zhou; Jingya Fu; Hong Hua; Xiaosong Liu
Journal:  Drug Des Devel Ther       Date:  2017-09-06       Impact factor: 4.162

5.  Vaginal and oral use of probiotics as adjunctive therapy to fluconazole in patients with vulvovaginal candidiasis: A clinical trial on Iranian women.

Authors:  Zahra Vahedpoor; Mahdi Abastabar; Mojtaba Sehat; Parisa Talebian; Tayebeh Felfelian Fini; Zahra Dastanpour; Iman Haghani; Ramtin Chelongarian; Mehdi Nazeri
Journal:  Curr Med Mycol       Date:  2021-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.